|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM18112100X |
003 |
DE-627 |
005 |
20231223160700.0 |
007 |
cr uuu---uuuuu |
008 |
231223s2008 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2008.05.011
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0604.xml
|
035 |
|
|
|a (DE-627)NLM18112100X
|
035 |
|
|
|a (NLM)18650128
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Lin, Ying-Ju
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a G/T polymorphism in the interleukin-2 exon 1 region among Han Chinese systemic lupus erythematosus patients in Taiwan
|
264 |
|
1 |
|c 2008
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 07.10.2008
|
500 |
|
|
|a Date Revised 15.09.2008
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Interleukin-2 (IL-2), one of the crucial immunoregulatory cytokines required for T lymphocyte activation, plays an important role in autoimmune diseases. An IL-2 genetic G/T polymorphism (rs2069763) has been linked with multiple sclerosis and rheumatoid arthritis. We tested a hypothesis that this polymorphism confers systemic lupus erythematosus (SLE) susceptibility. Study participants were Han Chinese SLE patients and a healthy control group in Taiwan. Our results indicate (a) a significantly higher G allele frequency in SLE patients (P=1.91 x 10(-14); OR=3.94; 95% CI=2.74-5.66), (b) a significantly higher G allele frequency in SLE patients with antinuclear antibodies (ANA) (P=0.033; OR=4.21; 95% CI=1.01-17.51) and (c) a significantly lower G allele frequency in SLE patients with discoid rash (P=0.019; OR=0.41; 95% CI=0.19-0.88). Our results suggest that this polymorphism may be involved in the genetic background of Taiwanese SLE
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
7 |
|a Interleukin-2
|2 NLM
|
700 |
1 |
|
|a Wan, Lei
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Sheu, Jim Jinn-Chyuan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Huang, Chung-Ming
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Lin, Cheng-Wen
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Lan, Yu-Ching
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Lai, Chih-Ho
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Hung, Chien-Hui
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Tsai, Yuhsin
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Tsai, Chang-Hai
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Lin, Wei-Yong
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Liu, Hsin-Ping
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Lin, Ting-Hsu
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Huang, Yu-Min
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Tsai, Fuu-Jen
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 129(2008), 1 vom: 15. Okt., Seite 36-9
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:129
|g year:2008
|g number:1
|g day:15
|g month:10
|g pages:36-9
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2008.05.011
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 129
|j 2008
|e 1
|b 15
|c 10
|h 36-9
|